SCHEMBL30220784

SCHEMBL30220784

Cc1noc(C)c1C(N)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.69
NPY2R P49146 1/20 0.51
BRD4 O60885 8/20 0.46
BRD2 P25440 2/20 0.46
ALDH1A1 P00352 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CREBBP Q92793 5/20 0.40
TDO2 P48775 1/20 0.40
KMT2A Q03164 2/20 0.39
ATM Q13315 1/20 0.39
CYP2D6 P10635 3/20 0.37
CYP2C19 P33261 2/20 0.37
CYP2C9 P11712 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2628020 0.79 GAA (0.65) GAANPY2RBRD4BRD2ALDH1A1
SCHEMBL16563808 0.76 NPSR1 (0.48) GAAALDH1A1KMT2APTGS2MEN1
SCHEMBL23950843 0.72 GAA (0.55) GAANPY2RBRD4BRD2ALDH1A1
SCHEMBL3163082 0.71 SLC6A3 (0.44) GAABRD4BRD2ALDH1A1TDO2
SCHEMBL12261572 0.70 NPBWR1 (0.42) GAABRD4ALDH1A1KMT2AMEN1
SCHEMBL2628017 0.70 GAA (0.56) GAANPY2RALDH1A1L3MBTL1KMT2A
Hydrochloric Acid SCHEMBL6326194 0.70 SLC6A3 (0.43) GAABRD4ALDH1A1TDO2TSHR
Hydrochloric Acid SCHEMBL6326189 0.70 SLC6A3 (0.43) GAABRD4ALDH1A1TDO2TSHR
SCHEMBL21406490 0.70 GAA (0.47) GAANPY2RBRD4BRD2ALDH1A1
SCHEMBL4223694 0.68 AKT2 (0.46) GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077342-B1 PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2025-12-10 EP disclosed
US-12391712-B2 Phosphate derivatives of RORgamma modulators and uses thereof GENFIT (FR) 2025-08-19 US disclosed
US-20230039185-A1 PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF GENFIT (FR) 2023-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12391712-B2 Phosphate derivatives of RORgamma modulators and uses thereof RORB, RORA, RORC GAA 886/4885NPY2R 938/4885BRD4 2113/4885
US-20230039185-A1 PHOSPHATE DERIVATIVES OF RORGAMMA MODULATORS AND USES THEREOF RORB, RORA, RORC GAA 886/4885NPY2R 938/4885BRD4 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.